Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-269774
Filing Date
2020-10-15
Accepted
2020-10-15 07:03:34
Documents
59
Period of Report
2020-12-04
Effectiveness Date
2020-10-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d34212ddef14a.htm DEF 14A 1201044
2 GRAPHIC g34212fotter001.jpg GRAPHIC 8728
3 GRAPHIC g34212g04f59.jpg GRAPHIC 146929
4 GRAPHIC g34212g07d79.jpg GRAPHIC 957
5 GRAPHIC g34212g10n13.jpg GRAPHIC 8583
6 GRAPHIC g34212g13k33.jpg GRAPHIC 3961
7 GRAPHIC g34212g15k25.jpg GRAPHIC 815
8 GRAPHIC g34212g16i72.jpg GRAPHIC 1070
9 GRAPHIC g34212g19h07.jpg GRAPHIC 8624
10 GRAPHIC g34212g19h65.jpg GRAPHIC 1315
11 GRAPHIC g34212g20j46.jpg GRAPHIC 11963
12 GRAPHIC g34212g22m32.jpg GRAPHIC 8656
13 GRAPHIC g34212g27n44.jpg GRAPHIC 1077
14 GRAPHIC g34212g28j21.jpg GRAPHIC 1512
15 GRAPHIC g34212g37k96.jpg GRAPHIC 790
16 GRAPHIC g34212g37w89.jpg GRAPHIC 986
17 GRAPHIC g34212g41j91.jpg GRAPHIC 769
18 GRAPHIC g34212g41x30.jpg GRAPHIC 11863
19 GRAPHIC g34212g41x74.jpg GRAPHIC 1046
20 GRAPHIC g34212g45h16.jpg GRAPHIC 1021
21 GRAPHIC g34212g46k52.jpg GRAPHIC 26836
22 GRAPHIC g34212g46q01.jpg GRAPHIC 1066
23 GRAPHIC g34212g48q89.jpg GRAPHIC 14518
24 GRAPHIC g34212g48w64.jpg GRAPHIC 966
25 GRAPHIC g34212g49b92.jpg GRAPHIC 9495
26 GRAPHIC g34212g55l66.jpg GRAPHIC 11529
27 GRAPHIC g34212g56o58.jpg GRAPHIC 11533
28 GRAPHIC g34212g58p41.jpg GRAPHIC 11406
29 GRAPHIC g34212g64k56.jpg GRAPHIC 11295
30 GRAPHIC g34212g66w91.jpg GRAPHIC 994
31 GRAPHIC g34212g66y83.jpg GRAPHIC 5107
32 GRAPHIC g34212g67h72.jpg GRAPHIC 1004
33 GRAPHIC g34212g71r02.jpg GRAPHIC 9403
34 GRAPHIC g34212g73s05.jpg GRAPHIC 15002
35 GRAPHIC g34212g77n07.jpg GRAPHIC 7575
36 GRAPHIC g34212g81o07.jpg GRAPHIC 14741
37 GRAPHIC g34212g81v30.jpg GRAPHIC 1118
38 GRAPHIC g34212g86q35.jpg GRAPHIC 3062
39 GRAPHIC g34212g87k86.jpg GRAPHIC 15062
40 GRAPHIC g34212g87z43.jpg GRAPHIC 8482
41 GRAPHIC g34212g90e81.jpg GRAPHIC 8370
42 GRAPHIC g34212g95b14.jpg GRAPHIC 16453
43 GRAPHIC g34212g97s63.jpg GRAPHIC 790
44 GRAPHIC g34212g98v83.jpg GRAPHIC 1014
45 GRAPHIC g34212g98x78.jpg GRAPHIC 15952
46 GRAPHIC g34212gra0443.jpg GRAPHIC 23718
47 GRAPHIC g34212graa029.jpg GRAPHIC 8316
48 GRAPHIC g34212graaa28.jpg GRAPHIC 55226
49 GRAPHIC g34212grab029.jpg GRAPHIC 8377
50 GRAPHIC g34212grac029.jpg GRAPHIC 8343
51 GRAPHIC g34212grad029.jpg GRAPHIC 8375
52 GRAPHIC g34212grae029.jpg GRAPHIC 8326
53 GRAPHIC g34212graf029.jpg GRAPHIC 8299
54 GRAPHIC g34212grag029.jpg GRAPHIC 8297
55 GRAPHIC g34212grah029.jpg GRAPHIC 8183
56 GRAPHIC g34212im1.jpg GRAPHIC 166894
57 GRAPHIC g34212sp0039.jpg GRAPHIC 33660
58 GRAPHIC g34212sp41.jpg GRAPHIC 26787
59 GRAPHIC g34212sp41a.jpg GRAPHIC 33597
  Complete submission text file 0001193125-20-269774.txt   2234548
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-26642 | Film No.: 201240302
SIC: 2835 In Vitro & In Vivo Diagnostic Substances